Ernest James Rin, MD | |
1300 N Vermont Ave, Los Angeles, CA 90027-6098 | |
(213) 413-3000 | |
Not Available |
Full Name | Ernest James Rin |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 1300 N Vermont Ave, Los Angeles, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023578101 | NPI | - | NPPES |
Entity Name | Mainegeneral Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669423380 PECOS PAC ID: 1254245715 Enrollment ID: O20031118000718 |
News Archive
BD, a leading global medical technology company announced today the launch of the BD U-500 Insulin Syringe, the first insulin syringe developed for people with diabetes taking Humulin R U-500 insulin, which is manufactured by Eli Lilly & Company.
The insight from experiments with rats could influence the design of hearing devices, MP3 music players and virtually any audio transmission technology, say the scientists.
Liggins Institute Director and trial Director Professor Peter Gluckman said the CoolCap trial results were the culmination of over 20 years work and provided the first evidence in humans that brain damage at birth could be treated. The findings offered hope for a new approach to a major set of clinical conditions, he said.
The skin cells of four adults with schizophrenia have provided an unprecedented "window" into how the disease began while they were still in the womb, according to a recent paper in Schizophrenia Research.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Ernest James Rin, MD 1 Brookdale Plz, Brooklyn, NY 11212-3198 Ph: () - | Ernest James Rin, MD 1300 N Vermont Ave, Los Angeles, CA 90027-6098 Ph: (213) 413-3000 |
News Archive
BD, a leading global medical technology company announced today the launch of the BD U-500 Insulin Syringe, the first insulin syringe developed for people with diabetes taking Humulin R U-500 insulin, which is manufactured by Eli Lilly & Company.
The insight from experiments with rats could influence the design of hearing devices, MP3 music players and virtually any audio transmission technology, say the scientists.
Liggins Institute Director and trial Director Professor Peter Gluckman said the CoolCap trial results were the culmination of over 20 years work and provided the first evidence in humans that brain damage at birth could be treated. The findings offered hope for a new approach to a major set of clinical conditions, he said.
The skin cells of four adults with schizophrenia have provided an unprecedented "window" into how the disease began while they were still in the womb, according to a recent paper in Schizophrenia Research.
› Verified 4 days ago
Dr. Tiffany Hackett, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8700 Beverly Blvd., Los Angeles, CA 90048 Phone: 310-967-1884 Fax: 310-967-1744 | |
Brennen J. Beatty, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Matthew S. Berry, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Phillip Gruber, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 N State St, Los Angeles, CA 90033 Phone: 323-226-6667 | |
Daniel Weingrow, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 757 Westwood Plz, Los Angeles, CA 90095 Phone: 310-825-2111 | |
Brian Truong, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 924 Westwood Blvd, Suite 300, Los Angeles, CA 90095 Phone: 310-794-0585 | |
Emily Michele Johnson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 San Pablo St, Los Angeles, CA 90033 Phone: 323-442-9922 |